Investigative Ophthalmology & Visual Science, Vol 38, 2081-2092, Copyright © 1997 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

A histologic study (including DNA quantification and Ki-67 labeling index) in uveal melanomas after brachytherapy with ruthenium plaques

H Schilling, KW Sehu and WR Lee
University of Essen, Eye Hospital, Germany.

PURPOSE: To investigate the proliferative potential and DNA damage in uveal melanomas treated by brachytherapy. METHODS: Forty-two enucleated eyes that had been treated with 106Ru/106Rh radioactive plaques for uveal melanoma were subgrouped according to the extent of irradiation damage. Cell proliferation was determined by immunoreactivity for the proliferation marker Ki-67 (Mib-1) and ploidy by quantitative DNA image analysis. Thirty globes containing uveal melanomas without prior brachytherapy served as a control group. RESULTS: The values for Ki-67 reactivity and ploidy could be correlated with radiation-induced changes within the tumors. In regions of the tumor where complete exposure to the prescribed radiation dose was assumed from the histologic findings, the Ki-67 index was close to or equal to zero. Hypoploidy was exclusive to irradiated tumors and was most often detected in effectively irradiated regions. Tumor regions classified as partially irradiated or recurrent showed an increase of Ki-67 indices and DNA content. Values obtained in recurrent tumors did not significantly differ from the control group. CONCLUSIONS: Tumor cell proliferation and variations in ploidy status could be detected after brachytherapy, but the response varied markedly both within individual tumors and within the irradiated group. Evidence of persisting proliferative potential could be obtained in ostensibly sterilized tumor tissue, but a negligible Ki-67 index and the presence of hypoploidy were considered to be reliable indicators for radiation- induced loss of proliferative potential.

This article has been cited by other articles:

				J. Pe'er, F. H Stefani, S. Seregard, T. Kivela, P. Lommatzsch, J. U Prause, B. Sobottka, B. Damato, and I. Chowers Cell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy: an EORTC ocular oncology group study Br. J. Ophthalmol., October 1, 2001; 85(10): 1208 - 1212. [Abstract] [Full Text] [PDF]

				F. Mouriaux, C.-A. Maurage, P. Labalette, B. Sablonnière, F. Malecaze, and J.-M. Darbon Cyclin-Dependent Kinase Inhibitory Protein Expression in Human Choroidal Melanoma Tumors Invest. Ophthalmol. Vis. Sci., September 1, 2000; 41(10): 2837 - 2843. [Abstract] [Full Text]

				C. Chiquet, J.-D. Grange, L. Ayzac, P. Chauvel, L.-M. Patricot, and M. Devouassoux-Shisheboran Effects of proton beam irradiation on uveal melanomas: a comparative study of Ki-67 expression in irradiated versus non-irradiated melanomas Br. J. Ophthalmol., January 1, 2000; 84(1): 98 - 102. [Abstract] [Full Text]

				C. M MOOY Ploidy analysis in uveal melanoma Br. J. Ophthalmol., December 1, 1998; 82(12): 1352 - 1353. [Full Text]

				S E Coupland, N Bechrakis, A Schüler, I Anagnostopoulos, M Hummel, N Bornfeld, and H Stein Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma Br. J. Ophthalmol., August 1, 1998; 82(8): 961 - 970. [Abstract] [Full Text]